Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-12-000589
Filing Date
2012-10-26
Accepted
2012-10-26 16:18:10
Documents
1
Group Members
ORACLE ASSOCIATES LLCORACLE INSTITUTIONAL PARTNERS L.P.ORACLE PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 a8519010a.htm SC 13D/A 162253
  Complete submission text file 0000899140-12-000589.txt   163886
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: SC 13D/A | Act: 34 | File No.: 005-33655 | Film No.: 121164662
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORACLE PARTNERS L P 200 GREENWICH AVENUE GREENWICH CT 06830
Business Address
FEINBERG LARRY N (Filed by) CIK: 0000926475 (see all company filings)

State of Incorp.: NY
Type: SC 13D/A